

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 8.75054490 |
| 2 | multicellular organismal water homeostasis (GO:0050891) | 8.57037216 |
| 3 | oligosaccharide catabolic process (GO:0009313) | 8.32375951 |
| 4 | glycosphingolipid catabolic process (GO:0046479) | 8.07438975 |
| 5 | keratinocyte differentiation (GO:0030216) | 7.98605095 |
| 6 | keratinocyte proliferation (GO:0043616) | 7.30680123 |
| 7 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 7.30284541 |
| 8 | glycolipid catabolic process (GO:0019377) | 7.28756992 |
| 9 | water homeostasis (GO:0030104) | 7.28730964 |
| 10 | ceramide catabolic process (GO:0046514) | 6.62079749 |
| 11 | peptide cross-linking (GO:0018149) | 6.34179875 |
| 12 | sphingoid metabolic process (GO:0046519) | 6.32557509 |
| 13 | epidermal cell differentiation (GO:0009913) | 6.18933138 |
| 14 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.05270680 |
| 15 | viral transcription (GO:0019083) | 5.98259091 |
| 16 | regulation of cholesterol storage (GO:0010885) | 5.79733014 |
| 17 | molting cycle (GO:0042303) | 5.78481474 |
| 18 | hair cycle (GO:0042633) | 5.78481474 |
| 19 | positive regulation of bone resorption (GO:0045780) | 5.71642458 |
| 20 | positive regulation of bone remodeling (GO:0046852) | 5.71642458 |
| 21 | translational termination (GO:0006415) | 5.65077962 |
| 22 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.55545210 |
| 23 | ribosomal small subunit biogenesis (GO:0042274) | 5.49704715 |
| 24 | regulation of phospholipase A2 activity (GO:0032429) | 5.45122503 |
| 25 | interferon-gamma secretion (GO:0072643) | 5.37112031 |
| 26 | epidermis development (GO:0008544) | 5.36637827 |
| 27 | keratinocyte development (GO:0003334) | 5.34485456 |
| 28 | sphingosine metabolic process (GO:0006670) | 5.32333723 |
| 29 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 5.31664073 |
| 30 | * amino sugar catabolic process (GO:0046348) | 5.14728198 |
| 31 | intermediate filament organization (GO:0045109) | 5.09956289 |
| 32 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.02277856 |
| 33 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.80333101 |
| 34 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.71577129 |
| 35 | regulation of ruffle assembly (GO:1900027) | 4.68555805 |
| 36 | diol metabolic process (GO:0034311) | 4.68195242 |
| 37 | sphingolipid catabolic process (GO:0030149) | 4.67376769 |
| 38 | skin morphogenesis (GO:0043589) | 4.60127491 |
| 39 | membrane lipid catabolic process (GO:0046466) | 4.57183611 |
| 40 | osteoclast differentiation (GO:0030316) | 4.53533814 |
| 41 | translational elongation (GO:0006414) | 4.48323893 |
| 42 | cellular extravasation (GO:0045123) | 4.41754296 |
| 43 | response to peptidoglycan (GO:0032494) | 4.41395026 |
| 44 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.41087694 |
| 45 | viral life cycle (GO:0019058) | 4.37689527 |
| 46 | protein targeting to ER (GO:0045047) | 4.33990718 |
| 47 | ganglioside metabolic process (GO:0001573) | 4.33839814 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 4.31459464 |
| 49 | maturation of SSU-rRNA (GO:0030490) | 4.31409225 |
| 50 | cotranslational protein targeting to membrane (GO:0006613) | 4.30966204 |
| 51 | cellular protein complex disassembly (GO:0043624) | 4.30873604 |
| 52 | regulation of monocyte differentiation (GO:0045655) | 4.27547956 |
| 53 | regulation of chemokine secretion (GO:0090196) | 4.25835854 |
| 54 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.20049213 |
| 55 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.14688807 |
| 56 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.10020763 |
| 57 | linoleic acid metabolic process (GO:0043651) | 4.08065106 |
| 58 | response to thyroid hormone (GO:0097066) | 4.05889889 |
| 59 | protein localization to endoplasmic reticulum (GO:0070972) | 4.02854279 |
| 60 | phagosome maturation (GO:0090382) | 4.02358318 |
| 61 | negative regulation of interleukin-12 production (GO:0032695) | 3.99646699 |
| 62 | regulation of hypersensitivity (GO:0002883) | 3.98454838 |
| 63 | peptide catabolic process (GO:0043171) | 3.93948501 |
| 64 | cardiac right ventricle morphogenesis (GO:0003215) | 3.93933977 |
| 65 | N-acetylneuraminate metabolic process (GO:0006054) | 3.93242583 |
| 66 | keratan sulfate catabolic process (GO:0042340) | 3.89914195 |
| 67 | barbed-end actin filament capping (GO:0051016) | 3.88469479 |
| 68 | positive regulation of tissue remodeling (GO:0034105) | 3.87102509 |
| 69 | ribosomal small subunit assembly (GO:0000028) | 3.86369304 |
| 70 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.86224343 |
| 71 | apoptotic cell clearance (GO:0043277) | 3.86060572 |
| 72 | positive regulation of chemokine secretion (GO:0090197) | 3.83757917 |
| 73 | fatty acid elongation (GO:0030497) | 3.83020267 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 3.82918204 |
| 75 | eosinophil chemotaxis (GO:0048245) | 3.71863860 |
| 76 | lipoxygenase pathway (GO:0019372) | 3.71736394 |
| 77 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.64663031 |
| 78 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64621944 |
| 79 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.64515917 |
| 80 | regulation of interleukin-8 secretion (GO:2000482) | 3.62341649 |
| 81 | ectoderm development (GO:0007398) | 3.61385859 |
| 82 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.60115398 |
| 83 | regulation of mononuclear cell migration (GO:0071675) | 3.58533412 |
| 84 | protein complex disassembly (GO:0043241) | 3.57542862 |
| 85 | negative regulation of stress fiber assembly (GO:0051497) | 3.53012367 |
| 86 | positive regulation of cholesterol efflux (GO:0010875) | 3.52531499 |
| 87 | translational initiation (GO:0006413) | 3.52418068 |
| 88 | gland morphogenesis (GO:0022612) | 3.47768791 |
| 89 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.45520631 |
| 90 | negative regulation of interleukin-2 production (GO:0032703) | 3.44390411 |
| 91 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.43559153 |
| 92 | negative regulation of cell fate specification (GO:0009996) | 3.42889874 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 3.42882797 |
| 94 | immunoglobulin mediated immune response (GO:0016064) | 3.41543942 |
| 95 | eosinophil migration (GO:0072677) | 3.41505937 |
| 96 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.40058963 |
| 97 | transferrin transport (GO:0033572) | 3.35974996 |
| 98 | regulation of superoxide anion generation (GO:0032928) | 3.35948709 |
| 99 | macrophage differentiation (GO:0030225) | 3.35413298 |
| 100 | iron ion import (GO:0097286) | 3.32838758 |
| 101 | atrioventricular valve morphogenesis (GO:0003181) | 3.32103583 |
| 102 | positive regulation of antigen processing and presentation (GO:0002579) | 3.31402663 |
| 103 | respiratory burst (GO:0045730) | 3.29313001 |
| 104 | macromolecular complex disassembly (GO:0032984) | 3.28444352 |
| 105 | fibrinolysis (GO:0042730) | 3.28428985 |
| 106 | ribosomal large subunit biogenesis (GO:0042273) | 3.27289720 |
| 107 | positive regulation of mast cell degranulation (GO:0043306) | 3.25668045 |
| 108 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.25668045 |
| 109 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.24957449 |
| 110 | intracellular pH reduction (GO:0051452) | 3.24376185 |
| 111 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.23983857 |
| 112 | positive regulation of leukocyte degranulation (GO:0043302) | 3.23638998 |
| 113 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.22647671 |
| 114 | prostanoid biosynthetic process (GO:0046457) | 3.21076446 |
| 115 | prostaglandin biosynthetic process (GO:0001516) | 3.21076446 |
| 116 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.19617350 |
| 117 | negative regulation of kidney development (GO:0090185) | 3.17807470 |
| 118 | negative regulation of cell fate commitment (GO:0010454) | 3.17416086 |
| 119 | positive regulation of mast cell activation (GO:0033005) | 3.16630148 |
| 120 | positive regulation of interleukin-4 production (GO:0032753) | 3.16340185 |
| 121 | detection of bacterium (GO:0016045) | 3.15383097 |
| 122 | pH reduction (GO:0045851) | 3.14428864 |
| 123 | regulation of cardioblast differentiation (GO:0051890) | 3.14191137 |
| 124 | ferric iron transport (GO:0015682) | 3.12487597 |
| 125 | trivalent inorganic cation transport (GO:0072512) | 3.12487597 |
| 126 | plasma lipoprotein particle clearance (GO:0034381) | 3.11353035 |
| 127 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09270267 |
| 128 | vitamin D metabolic process (GO:0042359) | 3.08706366 |
| 129 | protein targeting to membrane (GO:0006612) | 3.08409764 |
| 130 | positive regulation of osteoclast differentiation (GO:0045672) | 3.05431275 |
| 131 | positive regulation of vesicle fusion (GO:0031340) | 3.05147027 |
| 132 | regulation of bone resorption (GO:0045124) | 3.04252787 |
| 133 | pinocytosis (GO:0006907) | 3.03830180 |
| 134 | intermediate filament cytoskeleton organization (GO:0045104) | 3.02263311 |
| 135 | regulation of mast cell degranulation (GO:0043304) | 3.02040383 |
| 136 | positive regulation of sterol transport (GO:0032373) | 3.01332250 |
| 137 | positive regulation of cholesterol transport (GO:0032376) | 3.01332250 |
| 138 | dendritic cell differentiation (GO:0097028) | 3.00972087 |
| 139 | sympathetic nervous system development (GO:0048485) | 3.00635601 |
| 140 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.00031120 |
| 141 | primary alcohol catabolic process (GO:0034310) | 2.99615730 |
| 142 | negative regulation of lipid storage (GO:0010888) | 2.99433642 |
| 143 | granulocyte activation (GO:0036230) | 2.99402274 |
| 144 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.99371517 |
| 145 | detection of other organism (GO:0098543) | 2.97936207 |
| 146 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.96645886 |
| 147 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.95389845 |
| 148 | cellular response to interferon-alpha (GO:0035457) | 2.94905421 |
| 149 | lytic vacuole organization (GO:0080171) | 2.94395322 |
| 150 | lysosome organization (GO:0007040) | 2.94395322 |
| 151 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.94067626 |
| 152 | negative regulation of interferon-gamma production (GO:0032689) | 2.93441544 |
| 153 | intermediate filament-based process (GO:0045103) | 2.92576224 |
| 154 | regulation of cholesterol esterification (GO:0010872) | 2.91315843 |
| 155 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.91302084 |
| 156 | positive regulation of glomerulus development (GO:0090193) | 2.89844067 |
| 157 | negative regulation of acute inflammatory response (GO:0002674) | 2.89747664 |
| 158 | eyelid development in camera-type eye (GO:0061029) | 2.87816385 |
| 159 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.86559219 |
| 160 | macrophage activation involved in immune response (GO:0002281) | 2.85710666 |
| 161 | monocyte chemotaxis (GO:0002548) | 2.85618612 |
| 162 | cardiolipin metabolic process (GO:0032048) | 2.85610140 |
| 163 | cyclooxygenase pathway (GO:0019371) | 2.85103175 |
| 164 | mesenchymal to epithelial transition (GO:0060231) | 2.84456497 |
| 165 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.83684821 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.82796581 |
| 167 | inflammatory response to antigenic stimulus (GO:0002437) | 2.82219895 |
| 168 | phospholipid efflux (GO:0033700) | 2.81987568 |
| 169 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.81857386 |
| 170 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.81692167 |
| 171 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.81692167 |
| 172 | decidualization (GO:0046697) | 2.80675594 |
| 173 | neutrophil chemotaxis (GO:0030593) | 2.80469453 |
| 174 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79804537 |
| 175 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.79415678 |
| 176 | regulation of monocyte chemotaxis (GO:0090025) | 2.79117736 |
| 177 | protein localization to endosome (GO:0036010) | 2.78259953 |
| 178 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78206758 |
| 179 | iron ion transport (GO:0006826) | 2.77390670 |
| 180 | detection of molecule of bacterial origin (GO:0032490) | 2.77017930 |
| 181 | granulocyte chemotaxis (GO:0071621) | 2.76759333 |
| 182 | cell-substrate junction assembly (GO:0007044) | 2.76426939 |
| 183 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.74265763 |
| 184 | neutrophil migration (GO:1990266) | 2.72967287 |
| 185 | low-density lipoprotein particle remodeling (GO:0034374) | 2.72740796 |
| 186 | mannose metabolic process (GO:0006013) | 2.72673289 |
| 187 | skin development (GO:0043588) | 2.71682294 |
| 188 | response to lipoprotein particle (GO:0055094) | 2.71216013 |
| 189 | lipid storage (GO:0019915) | 2.70734166 |
| 190 | detection of external biotic stimulus (GO:0098581) | 2.70430745 |
| 191 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.69290142 |
| 192 | chemical homeostasis within a tissue (GO:0048875) | 2.68405401 |
| 193 | limb bud formation (GO:0060174) | 2.68271554 |
| 194 | lateral sprouting from an epithelium (GO:0060601) | 2.67140108 |
| 195 | epithelium development (GO:0060429) | 2.66455831 |
| 196 | desmosome organization (GO:0002934) | 15.1460292 |
| 197 | establishment of skin barrier (GO:0061436) | 14.1445943 |
| 198 | keratinization (GO:0031424) | 13.5284530 |
| 199 | regulation of water loss via skin (GO:0033561) | 12.7780670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.89273103 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.64585865 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.63055265 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.67795862 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.67194318 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19432222 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.02697653 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.88573508 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58060911 |
| 10 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 3.25103608 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 3.10980495 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.10800898 |
| 13 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 3.10188449 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04012932 |
| 15 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.90309567 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.52400626 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46444626 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41090836 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.40669246 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.37846836 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.32728177 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32072445 |
| 23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30195540 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.27342264 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22067927 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.20174911 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20079115 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08887750 |
| 29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.07306639 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05616974 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04530935 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 17.0332149 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96890393 |
| 34 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.94189599 |
| 35 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.94189599 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92983903 |
| 37 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92643502 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.90634719 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90398190 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82290195 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.82177701 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81325878 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.74902485 |
| 44 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73394440 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.69538441 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69497813 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65158987 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61856884 |
| 49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.58660608 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56623724 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54176874 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54033004 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52163940 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50822591 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49023790 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43679011 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43408207 |
| 58 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.42208408 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40252554 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.40222532 |
| 61 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.38744167 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36410481 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36229011 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35148947 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.32189735 |
| 66 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31901300 |
| 67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31036237 |
| 68 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.30432869 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29234141 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29076126 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25932495 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25609038 |
| 73 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23953617 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21980207 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19905895 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18989001 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18699541 |
| 78 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.18315494 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17618583 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17230311 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16748320 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15421215 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15267883 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13901725 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13112108 |
| 86 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.12403955 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.09798379 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 1.09793822 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08257008 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08047505 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07576463 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06898626 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05826925 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05109261 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04875012 |
| 96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03451916 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02698253 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02633077 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02611659 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02488220 |
| 101 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01874862 |
| 102 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00719322 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00396429 |
| 104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00374738 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00369413 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99216165 |
| 107 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98654384 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97833581 |
| 109 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97515260 |
| 110 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97232108 |
| 111 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96633602 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95180662 |
| 113 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.93560469 |
| 114 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93525612 |
| 115 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92885962 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91810295 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91564924 |
| 118 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91499731 |
| 119 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91294237 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90998104 |
| 121 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90997120 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90678282 |
| 123 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88486220 |
| 124 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88418449 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87499667 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87023534 |
| 127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.86967829 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86730451 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86223598 |
| 130 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84425616 |
| 131 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.84112481 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82876019 |
| 133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82852069 |
| 134 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.82529785 |
| 135 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81072124 |
| 136 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80368215 |
| 137 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80109215 |
| 138 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79758349 |
| 139 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78580480 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78353276 |
| 141 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77703148 |
| 142 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77388063 |
| 143 | MYB_26560356_Chip-Seq_TH1_Human | 0.76262458 |
| 144 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.74951964 |
| 145 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74646152 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74185580 |
| 147 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74010257 |
| 148 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.73838303 |
| 149 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73283383 |
| 150 | UTX_26944678_Chip-Seq_JUKART_Human | 0.72810348 |
| 151 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72671403 |
| 152 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.72398528 |
| 153 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.72362432 |
| 154 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70971308 |
| 155 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.70691300 |
| 156 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.70637973 |
| 157 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.70553369 |
| 158 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70182982 |
| 159 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.68716913 |
| 160 | VDR_22108803_ChIP-Seq_LS180_Human | 0.67982764 |
| 161 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.67433640 |
| 162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67028317 |
| 163 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.66606175 |
| 164 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.66145281 |
| 165 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.65073010 |
| 166 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.64556998 |
| 167 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64230134 |
| 168 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63383797 |
| 169 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62932485 |
| 170 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.62633389 |
| 171 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61939281 |
| 172 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.61311039 |
| 173 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.60998743 |
| 174 | TP53_16413492_ChIP-PET_HCT116_Human | 0.60263493 |
| 175 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.59685062 |
| 176 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.59195386 |
| 177 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.59015012 |
| 178 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.58583052 |
| 179 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.58536059 |
| 180 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58416139 |
| 181 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.57904795 |
| 182 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.56471384 |
| 183 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.56144568 |
| 184 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.56008480 |
| 185 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.55925180 |
| 186 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.54529409 |
| 187 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.54051924 |
| 188 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52069295 |
| 189 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51550932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 8.13934611 |
| 2 | MP0005275_abnormal_skin_tensile | 5.73543627 |
| 3 | MP0003941_abnormal_skin_development | 5.15478393 |
| 4 | MP0005501_abnormal_skin_physiology | 4.99140677 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 4.93792934 |
| 6 | MP0005058_abnormal_lysosome_morphology | 4.76367654 |
| 7 | MP0004381_abnormal_hair_follicle | 4.26197915 |
| 8 | MP0009840_abnormal_foam_cell | 3.92270427 |
| 9 | MP0000604_amyloidosis | 3.88267439 |
| 10 | MP0003172_abnormal_lysosome_physiology | 3.83803717 |
| 11 | MP0002060_abnormal_skin_morphology | 3.77404817 |
| 12 | MP0000383_abnormal_hair_follicle | 3.59275853 |
| 13 | MP0001216_abnormal_epidermal_layer | 3.57662427 |
| 14 | MP0002254_reproductive_system_inflammat | 3.50215229 |
| 15 | MP0006082_CNS_inflammation | 3.40363165 |
| 16 | MP0000579_abnormal_nail_morphology | 3.22658568 |
| 17 | MP0010771_integument_phenotype | 3.21881065 |
| 18 | MP0010678_abnormal_skin_adnexa | 3.18375313 |
| 19 | MP0003303_peritoneal_inflammation | 3.08822568 |
| 20 | MP0002098_abnormal_vibrissa_morphology | 2.89008377 |
| 21 | MP0000647_abnormal_sebaceous_gland | 2.86472440 |
| 22 | MP0003724_increased_susceptibility_to | 2.83726311 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.82500250 |
| 24 | MP0004947_skin_inflammation | 2.74890064 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 2.74853484 |
| 26 | MP0002419_abnormal_innate_immunity | 2.73975104 |
| 27 | MP0005451_abnormal_body_composition | 2.58362401 |
| 28 | MP0003329_amyloid_beta_deposits | 2.56815695 |
| 29 | MP0001835_abnormal_antigen_presentation | 2.55451902 |
| 30 | MP0000566_synostosis | 2.55235049 |
| 31 | MP0000467_abnormal_esophagus_morphology | 2.44059413 |
| 32 | MP0005671_abnormal_response_to | 2.39227130 |
| 33 | MP0000377_abnormal_hair_follicle | 2.35568846 |
| 34 | MP0009785_altered_susceptibility_to | 2.29620223 |
| 35 | MP0000343_altered_response_to | 2.28489406 |
| 36 | MP0001790_abnormal_immune_system | 2.11622435 |
| 37 | MP0005387_immune_system_phenotype | 2.11622435 |
| 38 | MP0005025_abnormal_response_to | 2.09324010 |
| 39 | MP0009379_abnormal_foot_pigmentation | 2.07133873 |
| 40 | MP0000427_abnormal_hair_cycle | 2.05875541 |
| 41 | MP0009278_abnormal_bone_marrow | 2.05608677 |
| 42 | MP0002009_preneoplasia | 2.04716598 |
| 43 | MP0001346_abnormal_lacrimal_gland | 2.04156170 |
| 44 | MP0005365_abnormal_bile_salt | 2.01843602 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.98463850 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.93883853 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.92283911 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.90927932 |
| 49 | MP0003075_altered_response_to | 1.89462128 |
| 50 | MP0003690_abnormal_glial_cell | 1.88892256 |
| 51 | MP0001853_heart_inflammation | 1.86446652 |
| 52 | MP0009931_abnormal_skin_appearance | 1.83549487 |
| 53 | MP0000762_abnormal_tongue_morphology | 1.75558738 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.74094575 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.74094575 |
| 56 | MP0001191_abnormal_skin_condition | 1.72001743 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.71751363 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.71227732 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.71004286 |
| 60 | MP0002723_abnormal_immune_serum | 1.63371426 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.60117237 |
| 62 | MP0003195_calcinosis | 1.56539625 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.55570468 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.55144718 |
| 65 | MP0001800_abnormal_humoral_immune | 1.48949202 |
| 66 | MP0002090_abnormal_vision | 1.48932599 |
| 67 | MP0002420_abnormal_adaptive_immunity | 1.48571398 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.47959234 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.47677731 |
| 70 | MP0001819_abnormal_immune_cell | 1.46424519 |
| 71 | MP0000685_abnormal_immune_system | 1.45190036 |
| 72 | MP0005310_abnormal_salivary_gland | 1.44237809 |
| 73 | MP0002405_respiratory_system_inflammati | 1.43381957 |
| 74 | MP0001851_eye_inflammation | 1.40555752 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.40257614 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.39262996 |
| 77 | MP0001243_abnormal_dermal_layer | 1.37071616 |
| 78 | MP0000367_abnormal_coat/_hair | 1.35820670 |
| 79 | MP0009764_decreased_sensitivity_to | 1.35362912 |
| 80 | MP0000920_abnormal_myelination | 1.31873758 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.27807960 |
| 82 | MP0004883_abnormal_blood_vessel | 1.25542518 |
| 83 | MP0008469_abnormal_protein_level | 1.22626330 |
| 84 | MP0000569_abnormal_digit_pigmentation | 1.21031200 |
| 85 | MP0003448_altered_tumor_morphology | 1.20899057 |
| 86 | MP0000371_diluted_coat_color | 1.15868656 |
| 87 | MP0001188_hyperpigmentation | 1.12847779 |
| 88 | MP0001340_abnormal_eyelid_morphology | 1.09179668 |
| 89 | MP0008260_abnormal_autophagy | 1.08720515 |
| 90 | MP0002234_abnormal_pharynx_morphology | 1.06759484 |
| 91 | MP0000858_altered_metastatic_potential | 1.04574938 |
| 92 | MP0003136_yellow_coat_color | 1.04461382 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 1.03924450 |
| 94 | MP0005166_decreased_susceptibility_to | 1.02625940 |
| 95 | MP0003632_abnormal_nervous_system | 1.01489735 |
| 96 | MP0008004_abnormal_stomach_pH | 0.96906321 |
| 97 | MP0005164_abnormal_response_to | 0.94652614 |
| 98 | MP0010030_abnormal_orbit_morphology | 0.94541491 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.93978357 |
| 100 | MP0003634_abnormal_glial_cell | 0.92564039 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.92243694 |
| 102 | MP0000716_abnormal_immune_system | 0.92126038 |
| 103 | MP0010352_gastrointestinal_tract_polyps | 0.91975625 |
| 104 | MP0004510_myositis | 0.89541766 |
| 105 | MP0005023_abnormal_wound_healing | 0.87821519 |
| 106 | MP0010155_abnormal_intestine_physiology | 0.85627577 |
| 107 | MP0003795_abnormal_bone_structure | 0.85614055 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.85374533 |
| 109 | MP0003191_abnormal_cellular_cholesterol | 0.82599364 |
| 110 | MP0000627_abnormal_mammary_gland | 0.80409032 |
| 111 | MP0009763_increased_sensitivity_to | 0.78279148 |
| 112 | MP0005165_increased_susceptibility_to | 0.78218251 |
| 113 | MP0002177_abnormal_outer_ear | 0.77028179 |
| 114 | MP0003091_abnormal_cell_migration | 0.76258867 |
| 115 | MP0009053_abnormal_anal_canal | 0.75010145 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.74714401 |
| 117 | MP0003879_abnormal_hair_cell | 0.74583579 |
| 118 | MP0000249_abnormal_blood_vessel | 0.72490198 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.71307571 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.70284583 |
| 121 | MP0006054_spinal_hemorrhage | 0.69657479 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.69642410 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.69524754 |
| 124 | MP0002006_tumorigenesis | 0.69170745 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.69119055 |
| 126 | MP0002429_abnormal_blood_cell | 0.68678058 |
| 127 | MP0010307_abnormal_tumor_latency | 0.68192149 |
| 128 | MP0009115_abnormal_fat_cell | 0.67544900 |
| 129 | MP0001958_emphysema | 0.65424428 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.64708152 |
| 131 | MP0005076_abnormal_cell_differentiation | 0.63966944 |
| 132 | MP0003631_nervous_system_phenotype | 0.63108620 |
| 133 | MP0002398_abnormal_bone_marrow | 0.62724535 |
| 134 | MP0005409_darkened_coat_color | 0.62517572 |
| 135 | MP0004130_abnormal_muscle_cell | 0.62439036 |
| 136 | MP0001784_abnormal_fluid_regulation | 0.62368042 |
| 137 | MP0002166_altered_tumor_susceptibility | 0.62130448 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.62116316 |
| 139 | MP0000609_abnormal_liver_physiology | 0.61914243 |
| 140 | MP0003633_abnormal_nervous_system | 0.59484275 |
| 141 | MP0002118_abnormal_lipid_homeostasis | 0.59384191 |
| 142 | MP0002277_abnormal_respiratory_mucosa | 0.57537033 |
| 143 | MP0003011_delayed_dark_adaptation | 0.56291365 |
| 144 | MP0003436_decreased_susceptibility_to | 0.55541556 |
| 145 | MP0003315_abnormal_perineum_morphology | 0.55445341 |
| 146 | MP0001849_ear_inflammation | 0.53302270 |
| 147 | MP0000465_gastrointestinal_hemorrhage | 0.52032557 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.51967031 |
| 149 | MP0002249_abnormal_larynx_morphology | 0.51903826 |
| 150 | MP0005075_abnormal_melanosome_morpholog | 0.51296778 |
| 151 | MP0002282_abnormal_trachea_morphology | 0.50793158 |
| 152 | MP0003763_abnormal_thymus_physiology | 0.49050646 |
| 153 | MP0003755_abnormal_palate_morphology | 0.46745255 |
| 154 | MP0003938_abnormal_ear_development | 0.46596780 |
| 155 | MP0002877_abnormal_melanocyte_morpholog | 0.43224610 |
| 156 | MP0000470_abnormal_stomach_morphology | 0.41145037 |
| 157 | MP0002111_abnormal_tail_morphology | 0.40971001 |
| 158 | MP0003638_abnormal_response/metabolism_ | 0.40755493 |
| 159 | MP0004272_abnormal_basement_membrane | 0.38847795 |
| 160 | MP0002148_abnormal_hypersensitivity_rea | 0.38525441 |
| 161 | MP0004264_abnormal_extraembryonic_tissu | 0.35454660 |
| 162 | MP0003950_abnormal_plasma_membrane | 0.34955646 |
| 163 | MP0002233_abnormal_nose_morphology | 0.34158828 |
| 164 | MP0003828_pulmonary_edema | 0.33553674 |
| 165 | MP0003718_maternal_effect | 0.32923709 |
| 166 | MP0000537_abnormal_urethra_morphology | 0.32113489 |
| 167 | MP0003385_abnormal_body_wall | 0.31275461 |
| 168 | MP0005508_abnormal_skeleton_morphology | 0.31082046 |
| 169 | MP0001984_abnormal_olfaction | 0.30912740 |
| 170 | MP0005666_abnormal_adipose_tissue | 0.30761881 |
| 171 | MP0004019_abnormal_vitamin_homeostasis | 0.30726062 |
| 172 | MP0000432_abnormal_head_morphology | 0.30542634 |
| 173 | MP0009250_abnormal_appendicular_skeleto | 0.29571234 |
| 174 | MP0000613_abnormal_salivary_gland | 0.28453312 |
| 175 | MP0005647_abnormal_sex_gland | 0.25663302 |
| 176 | MP0001666_abnormal_nutrient_absorption | 0.23040607 |
| 177 | MP0003936_abnormal_reproductive_system | 0.22970679 |
| 178 | MP0005367_renal/urinary_system_phenotyp | 0.22652133 |
| 179 | MP0000516_abnormal_urinary_system | 0.22652133 |
| 180 | MP0005408_hypopigmentation | 0.22558315 |
| 181 | MP0008961_abnormal_basal_metabolism | 0.22002489 |
| 182 | MP0002109_abnormal_limb_morphology | 0.18827367 |
| 183 | MP0005390_skeleton_phenotype | 0.18726614 |
| 184 | MP0000750_abnormal_muscle_regeneration | 0.18714454 |
| 185 | MP0005187_abnormal_penis_morphology | 0.18638265 |
| 186 | MP0005193_abnormal_anterior_eye | 0.17939278 |
| 187 | MP0002132_abnormal_respiratory_system | 0.17839887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 8.00443133 |
| 2 | Hypotrichosis (HP:0001006) | 7.40825712 |
| 3 | Plantar hyperkeratosis (HP:0007556) | 6.79423075 |
| 4 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 6.62111092 |
| 5 | Conjunctival hamartoma (HP:0100780) | 6.44380818 |
| 6 | Congenital ichthyosiform erythroderma (HP:0007431) | 6.36587293 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 6.32024725 |
| 8 | Palmoplantar hyperkeratosis (HP:0000972) | 6.20382186 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 6.15514938 |
| 10 | Erythema (HP:0010783) | 6.05608421 |
| 11 | Erythroderma (HP:0001019) | 5.95785990 |
| 12 | Woolly hair (HP:0002224) | 5.95720372 |
| 13 | Palmar hyperkeratosis (HP:0010765) | 5.84206879 |
| 14 | Onycholysis (HP:0001806) | 5.80988499 |
| 15 | Fragile nails (HP:0001808) | 5.60222443 |
| 16 | Right ventricular cardiomyopathy (HP:0011663) | 5.54378818 |
| 17 | Lip pit (HP:0100267) | 5.10403864 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.07406104 |
| 19 | Abnormality of macrophages (HP:0004311) | 5.06679535 |
| 20 | Parakeratosis (HP:0001036) | 5.00221679 |
| 21 | Disinhibition (HP:0000734) | 4.81089746 |
| 22 | Milia (HP:0001056) | 4.77019873 |
| 23 | Dysostosis multiplex (HP:0000943) | 4.71467487 |
| 24 | Loss of speech (HP:0002371) | 4.35218207 |
| 25 | Pili torti (HP:0003777) | 4.33178926 |
| 26 | Abnormal blistering of the skin (HP:0008066) | 4.32355361 |
| 27 | Myocardial infarction (HP:0001658) | 4.23252545 |
| 28 | Ectropion (HP:0000656) | 4.19569071 |
| 29 | Gangrene (HP:0100758) | 4.16278183 |
| 30 | Abnormality of nail color (HP:0100643) | 4.14849494 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 4.00328681 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.94644670 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.94644670 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.94644670 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 3.94189093 |
| 36 | Thick nail (HP:0001805) | 3.84041016 |
| 37 | Mucopolysacchariduria (HP:0008155) | 3.79394965 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.79394965 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.78862954 |
| 40 | Recurrent abscess formation (HP:0002722) | 3.77086879 |
| 41 | Hamartoma of the eye (HP:0010568) | 3.76381647 |
| 42 | Abnormality of the axillary hair (HP:0100134) | 3.71087937 |
| 43 | Abnormality of secondary sexual hair (HP:0009888) | 3.71087937 |
| 44 | Corneal erosion (HP:0200020) | 3.67366428 |
| 45 | Neurofibrillary tangles (HP:0002185) | 3.56908871 |
| 46 | Mutism (HP:0002300) | 3.53134515 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52761461 |
| 48 | Nail dystrophy (HP:0008404) | 3.52064290 |
| 49 | Apathy (HP:0000741) | 3.51267601 |
| 50 | Diminished motivation (HP:0000745) | 3.50137378 |
| 51 | Axonal loss (HP:0003447) | 3.47716986 |
| 52 | Popliteal pterygium (HP:0009756) | 3.44159605 |
| 53 | Reticulocytopenia (HP:0001896) | 3.37195478 |
| 54 | Hyporeflexia of lower limbs (HP:0002600) | 3.36794004 |
| 55 | Hypohidrosis (HP:0000966) | 3.36537989 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.31781781 |
| 57 | Sparse eyelashes (HP:0000653) | 3.31016085 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 3.21712686 |
| 59 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.21119634 |
| 60 | Palmoplantar keratoderma (HP:0000982) | 3.20233709 |
| 61 | Pruritus (HP:0000989) | 3.15926342 |
| 62 | Ventricular tachycardia (HP:0004756) | 3.14258219 |
| 63 | Natal tooth (HP:0000695) | 3.11667338 |
| 64 | Agnosia (HP:0010524) | 3.11649238 |
| 65 | Upper motor neuron abnormality (HP:0002127) | 3.10529953 |
| 66 | Sparse scalp hair (HP:0002209) | 3.03761865 |
| 67 | Advanced eruption of teeth (HP:0006288) | 3.00899167 |
| 68 | Metaphyseal irregularity (HP:0003025) | 2.99132873 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.92830831 |
| 70 | Abnormal hemoglobin (HP:0011902) | 2.86534304 |
| 71 | Atrophic scars (HP:0001075) | 2.84362443 |
| 72 | Acanthosis nigricans (HP:0000956) | 2.80520713 |
| 73 | Xanthomatosis (HP:0000991) | 2.79293731 |
| 74 | Purpura (HP:0000979) | 2.78150582 |
| 75 | Abnormality of the periventricular white matter (HP:0002518) | 2.76953500 |
| 76 | Inappropriate behavior (HP:0000719) | 2.76800935 |
| 77 | Poor head control (HP:0002421) | 2.74879782 |
| 78 | Concave nail (HP:0001598) | 2.72521536 |
| 79 | Congenital, generalized hypertrichosis (HP:0004540) | 2.70078051 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 2.69023265 |
| 81 | Abnormal hair laboratory examination (HP:0003328) | 2.67698516 |
| 82 | Abnormal number of erythroid precursors (HP:0012131) | 2.62088538 |
| 83 | Ridged nail (HP:0001807) | 2.61712415 |
| 84 | Alopecia of scalp (HP:0002293) | 2.61271780 |
| 85 | Hypoplastic labia majora (HP:0000059) | 2.60981143 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.60013319 |
| 87 | Aplasia cutis congenita (HP:0001057) | 2.58237332 |
| 88 | Curly hair (HP:0002212) | 2.57716995 |
| 89 | Nuclear cataract (HP:0100018) | 2.57668802 |
| 90 | Abnormality of the salivary glands (HP:0010286) | 2.57194094 |
| 91 | Neuronal loss in central nervous system (HP:0002529) | 2.56839222 |
| 92 | Prostate neoplasm (HP:0100787) | 2.55331966 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 2.54090529 |
| 94 | Skin nodule (HP:0200036) | 2.49708278 |
| 95 | Protuberant abdomen (HP:0001538) | 2.48983595 |
| 96 | Epidermoid cyst (HP:0200040) | 2.47951388 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 2.46860067 |
| 98 | Pterygium (HP:0001059) | 2.45405418 |
| 99 | Areflexia of lower limbs (HP:0002522) | 2.45221988 |
| 100 | Multiple enchondromatosis (HP:0005701) | 2.43974237 |
| 101 | Abnormality of the labia majora (HP:0012881) | 2.36722136 |
| 102 | Macrocytic anemia (HP:0001972) | 2.35521356 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.34220710 |
| 104 | Dementia (HP:0000726) | 2.32351180 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31257929 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30716705 |
| 107 | Obstructive lung disease (HP:0006536) | 2.30716705 |
| 108 | Personality changes (HP:0000751) | 2.30407868 |
| 109 | Recurrent skin infections (HP:0001581) | 2.26382399 |
| 110 | Paralysis (HP:0003470) | 2.23393553 |
| 111 | Retinal atrophy (HP:0001105) | 2.23025076 |
| 112 | Thoracic kyphosis (HP:0002942) | 2.19949088 |
| 113 | Nausea (HP:0002018) | 2.19183745 |
| 114 | Pathologic fracture (HP:0002756) | 2.16909517 |
| 115 | Septate vagina (HP:0001153) | 2.16798485 |
| 116 | Conical tooth (HP:0000698) | 2.14574314 |
| 117 | Global brain atrophy (HP:0002283) | 2.11568671 |
| 118 | Cardiomegaly (HP:0001640) | 2.11511118 |
| 119 | Increased serum ferritin (HP:0003281) | 2.10494950 |
| 120 | T lymphocytopenia (HP:0005403) | 2.10210800 |
| 121 | Bone pain (HP:0002653) | 2.08213335 |
| 122 | Eczematoid dermatitis (HP:0000976) | 2.08125439 |
| 123 | Neoplasm of head and neck (HP:0012288) | 2.03776865 |
| 124 | Esophageal neoplasm (HP:0100751) | 2.03776865 |
| 125 | J-shaped sella turcica (HP:0002680) | 2.03476036 |
| 126 | Peripheral demyelination (HP:0011096) | 2.03468572 |
| 127 | Dry skin (HP:0000958) | 2.02834621 |
| 128 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00635548 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 2.00479787 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 10.7172306 |
| 131 | Abnormality of liposaccharide metabolism (HP:0010968) | 10.7172306 |
| 132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 10.7172306 |
| 133 | Petechiae (HP:0000967) | 1.99747956 |
| 134 | Hyperventilation (HP:0002883) | 1.98598286 |
| 135 | Pallor (HP:0000980) | 1.96918813 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.96222959 |
| 137 | Ventricular fibrillation (HP:0001663) | 1.95500292 |
| 138 | Dehydration (HP:0001944) | 1.94663125 |
| 139 | Anhidrosis (HP:0000970) | 1.94598474 |
| 140 | Blepharitis (HP:0000498) | 1.94274371 |
| 141 | Glomerulonephritis (HP:0000099) | 1.93871419 |
| 142 | Increased CSF protein (HP:0002922) | 1.93522005 |
| 143 | Gingivitis (HP:0000230) | 1.93488370 |
| 144 | Prolonged neonatal jaundice (HP:0006579) | 1.92781194 |
| 145 | Esophageal atresia (HP:0002032) | 1.92178574 |
| 146 | Skin ulcer (HP:0200042) | 1.91157701 |
| 147 | Hamartoma (HP:0010566) | 1.90955180 |
| 148 | Absent eyebrow (HP:0002223) | 1.89467904 |
| 149 | Increased connective tissue (HP:0009025) | 1.88896687 |
| 150 | Recurrent fungal infections (HP:0002841) | 1.88710122 |
| 151 | Abnormality of the prostate (HP:0008775) | 1.88015547 |
| 152 | Oligodontia (HP:0000677) | 1.87687017 |
| 153 | Supranuclear gaze palsy (HP:0000605) | 1.87189637 |
| 154 | Hypoplasia of dental enamel (HP:0006297) | 1.86901441 |
| 155 | Brittle hair (HP:0002299) | 1.85449226 |
| 156 | Multiple lipomas (HP:0001012) | 1.85157415 |
| 157 | Abnormality of T cell number (HP:0011839) | 1.84296728 |
| 158 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83328081 |
| 159 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83328081 |
| 160 | Aplasia involving bones of the extremities (HP:0009825) | 1.83328081 |
| 161 | Lack of skin elasticity (HP:0100679) | 1.83093529 |
| 162 | Abnormality of the gastric mucosa (HP:0004295) | 1.80483671 |
| 163 | Stomatitis (HP:0010280) | 1.80219125 |
| 164 | Abnormality of the lumbar spine (HP:0100712) | 1.79647307 |
| 165 | Stenosis of the external auditory canal (HP:0000402) | 1.79156120 |
| 166 | Amaurosis fugax (HP:0100576) | 1.78851467 |
| 167 | Fatigable weakness (HP:0003473) | 1.78389766 |
| 168 | Abnormality of the neuromuscular junction (HP:0003398) | 1.78389766 |
| 169 | Hyperhidrosis (HP:0000975) | 1.76734376 |
| 170 | Hypoparathyroidism (HP:0000829) | 1.76635285 |
| 171 | Abnormality of iron homeostasis (HP:0011031) | 1.73826838 |
| 172 | Premature loss of primary teeth (HP:0006323) | 1.72837337 |
| 173 | Hypodontia (HP:0000668) | 1.72446808 |
| 174 | Pulmonary infiltrates (HP:0002113) | 1.71533666 |
| 175 | Restrictive lung disease (HP:0002091) | 1.71252512 |
| 176 | Ulnar claw (HP:0001178) | 1.68872704 |
| 177 | Ovoid vertebral bodies (HP:0003300) | 1.68128291 |
| 178 | Steatorrhea (HP:0002570) | 1.67419768 |
| 179 | Malignant hyperthermia (HP:0002047) | 1.64299244 |
| 180 | Nasolacrimal duct obstruction (HP:0000579) | 1.63395091 |
| 181 | Exercise-induced myalgia (HP:0003738) | 1.62239542 |
| 182 | Hypercholesterolemia (HP:0003124) | 1.61570263 |
| 183 | Severe Myopia (HP:0011003) | 1.61125721 |
| 184 | Amyloidosis (HP:0011034) | 1.60969220 |
| 185 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.60446320 |
| 186 | Recurrent cutaneous fungal infections (HP:0011370) | 1.60446320 |
| 187 | Fragile skin (HP:0001030) | 1.59270111 |
| 188 | Osteomyelitis (HP:0002754) | 1.57673440 |
| 189 | Melanocytic nevus (HP:0000995) | 1.57005920 |
| 190 | Combined immunodeficiency (HP:0005387) | 1.56122783 |
| 191 | Albinism (HP:0001022) | 1.55689501 |
| 192 | Orchitis (HP:0100796) | 1.55595462 |
| 193 | Tubulointerstitial fibrosis (HP:0005576) | 1.55564880 |
| 194 | Sepsis (HP:0100806) | 1.55095894 |
| 195 | Labial hypoplasia (HP:0000066) | 1.54431340 |
| 196 | Myopathic facies (HP:0002058) | 1.53783156 |
| 197 | Skin pits (HP:0100276) | 1.52046772 |
| 198 | Neonatal death (HP:0003811) | 1.51935540 |
| 199 | Trismus (HP:0000211) | 1.51757639 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK3 | 5.57968764 |
| 2 | MST1R | 5.40116638 |
| 3 | MAP3K3 | 4.76695142 |
| 4 | MAP3K2 | 3.59653607 |
| 5 | MST4 | 3.42462648 |
| 6 | FER | 3.30265575 |
| 7 | PDK2 | 2.94727567 |
| 8 | RPS6KB2 | 2.88560038 |
| 9 | PIM2 | 2.86553225 |
| 10 | ACVR1B | 2.36169432 |
| 11 | TRPM7 | 2.32977691 |
| 12 | CSK | 2.30906390 |
| 13 | CAMKK2 | 2.29988421 |
| 14 | NEK9 | 2.14512314 |
| 15 | CAMK1D | 2.03732749 |
| 16 | FGFR2 | 1.88580638 |
| 17 | STK24 | 1.85595177 |
| 18 | DDR2 | 1.79402971 |
| 19 | ZAP70 | 1.78414413 |
| 20 | LRRK2 | 1.76989136 |
| 21 | TBK1 | 1.70182920 |
| 22 | PIK3CG | 1.69794446 |
| 23 | EPHB2 | 1.65060749 |
| 24 | MATK | 1.64918290 |
| 25 | MAP2K6 | 1.64615573 |
| 26 | BLK | 1.64032288 |
| 27 | MET | 1.61538784 |
| 28 | PRPF4B | 1.60374018 |
| 29 | TESK1 | 1.58446559 |
| 30 | MAP3K13 | 1.58224763 |
| 31 | TAOK2 | 1.57005387 |
| 32 | MAP4K1 | 1.51324691 |
| 33 | MAPKAPK5 | 1.49534276 |
| 34 | CDC42BPA | 1.48157684 |
| 35 | EPHA2 | 1.47477968 |
| 36 | ERN1 | 1.45414793 |
| 37 | FGFR1 | 1.44379589 |
| 38 | TESK2 | 1.42698910 |
| 39 | ERBB3 | 1.42040009 |
| 40 | ADRBK2 | 1.36506448 |
| 41 | MOS | 1.32760654 |
| 42 | NTRK2 | 1.31498540 |
| 43 | LATS1 | 1.29234151 |
| 44 | EEF2K | 1.22568859 |
| 45 | STK10 | 1.21565561 |
| 46 | SYK | 1.18642816 |
| 47 | JAK1 | 1.16800037 |
| 48 | TAOK1 | 1.16707756 |
| 49 | MARK3 | 1.15661903 |
| 50 | EPHA3 | 1.14642900 |
| 51 | CAMK1G | 1.12810776 |
| 52 | PTK6 | 1.12323686 |
| 53 | PDPK1 | 1.12223400 |
| 54 | TXK | 1.11310974 |
| 55 | MAP3K1 | 1.10979691 |
| 56 | FGFR4 | 1.08458501 |
| 57 | LYN | 1.08405955 |
| 58 | JAK3 | 1.07488297 |
| 59 | IRAK4 | 1.05469833 |
| 60 | FES | 1.04243279 |
| 61 | TTN | 1.02259604 |
| 62 | MAP3K11 | 1.01926228 |
| 63 | DYRK1B | 1.01697496 |
| 64 | OBSCN | 0.97662297 |
| 65 | BCR | 0.93112954 |
| 66 | MAP3K14 | 0.92957218 |
| 67 | MAPKAPK2 | 0.90725451 |
| 68 | TYK2 | 0.88868954 |
| 69 | PDK1 | 0.88599147 |
| 70 | BMPR2 | 0.88526412 |
| 71 | PAK4 | 0.88037763 |
| 72 | LCK | 0.83926628 |
| 73 | KIT | 0.83414507 |
| 74 | RPS6KA4 | 0.83096200 |
| 75 | CDK3 | 0.79988684 |
| 76 | CSF1R | 0.79514413 |
| 77 | FGFR3 | 0.78841384 |
| 78 | CDK6 | 0.76991717 |
| 79 | BTK | 0.76649523 |
| 80 | SGK3 | 0.75185958 |
| 81 | LIMK1 | 0.74104674 |
| 82 | DAPK2 | 0.72583939 |
| 83 | ARAF | 0.72519411 |
| 84 | IKBKB | 0.67931127 |
| 85 | IRAK3 | 0.67797092 |
| 86 | LATS2 | 0.66353254 |
| 87 | PRKG2 | 0.65655496 |
| 88 | IRAK2 | 0.65167214 |
| 89 | KSR2 | 0.64906032 |
| 90 | GRK1 | 0.64623345 |
| 91 | MAP2K2 | 0.63185213 |
| 92 | MAP3K6 | 0.62517816 |
| 93 | TAOK3 | 0.61349608 |
| 94 | TGFBR2 | 0.61058136 |
| 95 | TYRO3 | 0.59747313 |
| 96 | MAP2K3 | 0.58788383 |
| 97 | NME2 | 0.58039503 |
| 98 | PRKCI | 0.57784634 |
| 99 | RIPK4 | 0.57723057 |
| 100 | CAMKK1 | 0.57588001 |
| 101 | PRKD1 | 0.56268544 |
| 102 | MAPK15 | 0.55965590 |
| 103 | SGK2 | 0.55082069 |
| 104 | RPS6KA6 | 0.52523652 |
| 105 | MAPK7 | 0.50287515 |
| 106 | MAP3K5 | 0.50159398 |
| 107 | STK11 | 0.49051322 |
| 108 | MAP3K8 | 0.48278700 |
| 109 | IRAK1 | 0.48268844 |
| 110 | IKBKE | 0.48187166 |
| 111 | EIF2AK2 | 0.48055135 |
| 112 | TTK | 0.47474889 |
| 113 | ITK | 0.47096063 |
| 114 | GRK7 | 0.46927737 |
| 115 | SCYL2 | 0.45574073 |
| 116 | BRAF | 0.44591055 |
| 117 | ILK | 0.44477288 |
| 118 | MAP2K1 | 0.43905349 |
| 119 | STK3 | 0.43295810 |
| 120 | CAMK4 | 0.42936541 |
| 121 | RPS6KA1 | 0.42428995 |
| 122 | BRSK2 | 0.41688077 |
| 123 | EPHB1 | 0.41635371 |
| 124 | ERBB4 | 0.40527588 |
| 125 | PAK3 | 0.39629991 |
| 126 | TIE1 | 0.39103263 |
| 127 | CHUK | 0.38740962 |
| 128 | PRKD2 | 0.38521313 |
| 129 | DMPK | 0.38331647 |
| 130 | ADRBK1 | 0.37924012 |
| 131 | RIPK1 | 0.36457953 |
| 132 | FYN | 0.36128758 |
| 133 | AURKB | 0.35974448 |
| 134 | GSK3A | 0.34799976 |
| 135 | MAP3K12 | 0.34404804 |
| 136 | PRKCE | 0.33749689 |
| 137 | PIM1 | 0.33018088 |
| 138 | BMX | 0.32918797 |
| 139 | PRKCQ | 0.32550028 |
| 140 | RPS6KL1 | 0.32197508 |
| 141 | RPS6KC1 | 0.32197508 |
| 142 | PRKCD | 0.32144660 |
| 143 | EPHA4 | 0.32095891 |
| 144 | FGR | 0.32088452 |
| 145 | PTK2 | 0.32055341 |
| 146 | BMPR1B | 0.31093598 |
| 147 | DYRK3 | 0.29568412 |
| 148 | MAPK4 | 0.29428951 |
| 149 | CSNK1D | 0.28588014 |
| 150 | ABL1 | 0.26926686 |
| 151 | HCK | 0.26245689 |
| 152 | JAK2 | 0.25623913 |
| 153 | MAP2K4 | 0.25518529 |
| 154 | RPS6KA2 | 0.25266695 |
| 155 | MAPK12 | 0.22470138 |
| 156 | HIPK2 | 0.22380704 |
| 157 | ABL2 | 0.21864750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.60900834 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 4.86728534 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.58698926 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 4.28675661 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.77217796 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.68411383 |
| 7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.40868585 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.30429251 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.11670896 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.09452758 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.99546162 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.55124148 |
| 13 | Phagosome_Homo sapiens_hsa04145 | 2.43703627 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41528189 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.34133365 |
| 16 | Asthma_Homo sapiens_hsa05310 | 2.27700791 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.22184075 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21172655 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.16192972 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 2.08914154 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.01072531 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00231861 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.94326024 |
| 24 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.85744815 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83300716 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82490131 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76443879 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70962393 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63032360 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61895348 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.55389576 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.52123064 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51024645 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45939632 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42963773 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.42255853 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.42030574 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40049824 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37675557 |
| 40 | Adherens junction_Homo sapiens_hsa04520 | 1.36929231 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36395400 |
| 42 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.36158574 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.29800556 |
| 44 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25946720 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25781615 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 1.23705635 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22908701 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21922906 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21040375 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.20622858 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.19721304 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18003127 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14485165 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.14412187 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13221950 |
| 56 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.12140367 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10066049 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08834954 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 1.07645475 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07587086 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07149623 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06566513 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 1.06350852 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03019474 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.99650015 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99417573 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97209410 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.95515937 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94247401 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92407435 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91590258 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.90067770 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.88009780 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85908852 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84159847 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82093265 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80948165 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80370392 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79397967 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77614057 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75599213 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.74863039 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74672600 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74029854 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72216189 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71752577 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71219359 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70958860 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.68540213 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67853597 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67477215 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.66780948 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66458791 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66309911 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.65651950 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.64754862 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61487599 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.61323915 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.60283429 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58968285 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57440908 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57055207 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56501305 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53783426 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52995464 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.52240336 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50743779 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.50694936 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49905893 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49507303 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48185074 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47500957 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47284441 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47256591 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.46019145 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45765602 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.45235441 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.43623980 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43329035 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42359702 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41963782 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40396224 |
| 123 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39709232 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39623128 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.39541042 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37625954 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37399462 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37387643 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37349609 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37149175 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36911787 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36851934 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36409371 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35174264 |
| 135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35024811 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34059457 |
| 137 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33552864 |
| 138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33528734 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33257430 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32559586 |
| 141 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31974364 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31140772 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30644389 |
| 144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30624198 |
| 145 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29851456 |
| 146 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29444563 |
| 147 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.29251234 |
| 148 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.29029927 |
| 149 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28897736 |
| 150 | Salmonella infection_Homo sapiens_hsa05132 | 0.28007323 |
| 151 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27873520 |
| 152 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27284320 |
| 153 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27271258 |
| 154 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27077323 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.26636246 |
| 156 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26042246 |
| 157 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24892544 |
| 158 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24844510 |
| 159 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22266744 |
| 160 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21847324 |
| 161 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21082817 |
| 162 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20942883 |
| 163 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19292237 |
| 164 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.15472491 |
| 165 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.15281795 |
| 166 | Insulin resistance_Homo sapiens_hsa04931 | 0.15161040 |

